Clinical trials
Phase 1 Multiple Sclerosis, Relapsing-Remitting trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 3 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 7 |
| 2011 | 4 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 4 |
| 2017 | 2 |
| 2018 | 2 |
| 2020 | 3 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 32 |
| Terminated | 6 |
| Unknown status | 5 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 6 |
| Biogen | 4 |
| Tanabe Pharma Corporation | 3 |
| Banner Life Sciences LLC | 2 |
| Centre Hospitalier Universitaire Vaudois | 2 |
| Hoffmann-La Roche | 2 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 2 |
| University of Wisconsin, Madison | 2 |
| Aaron Boster | 1 |
| Acorda Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis, Relapsing-Remitting | 47 |
| Multiple Sclerosis | 24 |
| Multiple Sclerosis, Chronic Progressive | 9 |
| Autoimmune Diseases | 2 |
| Ataxia | 1 |
| Disease Progression | 1 |
| Myelitis | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.